Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cesar De Cesar Netto

Orthopaedic Surgery Iowa City, IA Medical Doctor

NPI 1326494642 CMS profile 1448851

200 Hawkins Dr, Iowa City, IA 52242

Open in the dashboard

General payments

$692,986

407 records reported · program years 2019–2025

Research payments

$2,826

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$1,481,910

7 holdings reported · through program year 2025

Research they led as principal investigator

$160,995 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Cesar De Cesar Netto of Iowa City, IA is reported in the CMS Open Payments database as having received $692,986 across 407 general payments and $2,826 in research payments paid to them. Separately, studies naming them as principal investigator received $160,995 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,481,910 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

15 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $77,509 94
2024 General $103,635 46
2024 Research $2,826 1
2023 General $150,018 83
2022 General $142,627 52
2021 General $106,159 69
2020 General $7,586 17
2019 General $105,453 46
2025 Ownership $51,475 1
2024 Ownership $87,274 1
2023 Ownership $293,161 1
2022 Ownership $375,000 1
2021 Ownership $375,000 1
2020 Ownership $150,000 1
2019 Ownership $150,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cesar De Cesar Netto
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Cesar De Cesar Netto were reported at $77,509. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Cesar De Cesar Netto Orthopaedic Surgery median Middle half National median
2019 $105,453 $644 $140–$2,844 $163
2020 $7,586 $312 $75–$1,860 $114
2021 $106,159 $520 $117–$2,495 $132
2022 $142,627 $598 $128–$2,731 $149
2023 $150,018 $461 $128–$2,264 $160
2024 $103,635 $497 $134–$2,475 $164
2025 $77,509 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragon 28, Inc. $393,395 181 payments
  2. CurveBeam LLC $102,150 6 payments
  3. Arthrex, Inc. $56,437 40 payments
  4. Zimmer Biomet Holdings, Inc. $33,403 71 payments
  5. Extremity Medical $25,167 8 payments
  6. Medartis Inc. $21,786 17 payments
  7. Stryker Corporation $15,427 15 payments
  8. Djo, LLC $9,300 1 payment
  9. International Life Sciences $8,000 2 payments
  10. Nextremity Solutions Inc. $7,630 1 payment
  11. Other $20,291 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $569,992 60 payments
  2. Travel and Lodging $68,926 139 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,750 5 payments
  4. Food and Beverage $14,518 187 payments
  5. Grant $9,300 1 payment
  6. Education $2,403 3 payments
  7. Royalty or License $860 11 payments
  8. Entertainment $238 1 payment
Products named General payments · program years 2019–2025
  1. PORTFOLIO $206,399 99 payments
  2. Product Portfolio $179,843 28 payments
  3. APTUS $21,751 16 payments
  4. InCore Lapidus $15,250 5 payments
  5. INVISION $10,005 2 payments
  6. Arthrex $6,146 2 payments
  7. Hindfoot $5,814 4 payments
  8. Trabecular Metal $4,507 24 payments
  9. VANTAGE $3,321 6 payments
  10. PROSTEP $2,875 2 payments
  11. Other $22,920 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Paragon 28, Inc. $2,826 1 payment

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$44,729

Medicare's payments for the services billed

Medicare patients

127

Average age 71

Services billed

418

83 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Depression 22%
Osteoporosis 20%
Diabetes 18%
Ischemic heart disease 17%
Chronic kidney disease 17%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

408 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record